Serum Electrolyte Dysregulation and Inflammatory Burden in Type 2 Diabetes: Development of a Novel Electrolyte-Inflammation Risk Score for Predicting Glycemic Control and Cardiovascular Complications
DOI:
https://doi.org/10.12982/BSCM.2026.47Keywords:
type 2 diabetes mellitus, electrolyte imbalance, inflammation, risk assessment, glycemic control, C-reactive proteinAbstract
Objective This study aimed to develop and validate a novel Electrolyte-Inflammation Risk Score (EIRS) integrating serum electrolytes and high-sensitivity C-reactive protein (hs-CRP), to predict glycemic control and cardiovascular risk in patients with type 2 diabetes mellitus (T2DM).
Methods A cross-sectional case-control study was conducted at Sri Lalithambigai Medical College, Chennai, involving 100 participants (50 patients with T2DM and 50 age-matched healthy controls). Fasting blood glucose, HbA1c (measured by HPLC using the Bio-Rad D-10 system), serum
sodium, potassium, and chloride (measured using an ion-selective electrode on the Roche Cobas), magnesium (measured by the xylidyl blue colorimetric method), and hs-CRP (measured by a particle-enhanced immunoturbidimetric assay) were measured. Statistical analysis included independent t-tests, Pearson correlation, multivariate logistic regression, and ROC curve analysis (SPSS version 28.0; p < 0.05).
Results T2DM patients exhibited significant electrolyte imbalances compared with controls: elevated potassium (5.40 ± 0.65 vs. 4.16 ± 0.82 mmol/L), increased sodium (142.6 ± 3.5 vs. 138.2 ± 2.3 mmol/L), reduced magnesium (1.8 ± 0.4 vs. 2.1 ± 0.3 mg/dL), and markedly elevated hs-CRP (4.8 ± 2.1 vs. 1.1 ± 0.7 mg/L; all p < 0.001 or p < 0.05). Multivariate logistic regression identified elevated sodium (OR = 2.84, 95% CI: 1.23–6.57, p = 0.015), elevated potassium (OR = 3.42, 95% CI: 1.45–8.08, p = 0.005), elevated hs-CRP (OR = 4.73, 95% CI: 2.15–10.41, p < 0.001), and higher BMI (OR = 1.12 per kg/m², 95% CI: 1.01–1.24, p = 0.031) as independent predictors of HbA1c > 8%. The EIRS, which is based on the four laboratory parameters, achieved an AUC of 0.847 (95% CI: 0.765–0.929, p < 0.001) at an optimal cut-off of ≥ 4 points, with 84% sensitivity and 78% specificity. High-risk patients (score 6–8) had 100% poor glycemic control and a 78% incidence of cardiovascular events, compared with 67% and 33% in moderate-risk and 13% and 8% in low-risk patients, respectively.
Conclusion The EIRS effectively identifies patients with T2DM at high risk of poor glycemic control and cardiovascular complications, offering a practical tool for the simultaneous assessment of metabolic and inflammatory risk.
References
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21: 6275. PubMed PMID: 32872570
Cao R, Tian H, Zhang Y, Liu G, Xu H, Rao G, et al. Signaling pathways and intervention for therapy of type 2 diabetes mellitus. MedComm (2020). 2023;4:e283. PubMed PMID: 37303813
Khan RN, Saba F, Kausar SF, Siddiqui MH. Pattern of electrolyte imbalance in type 2 diabetes patients: Experience from a tertiary care hospital. Pak J Med Sci. 2019;35:797-801.
Eshetu B, Worede A, Fentie A, Chane E, Fetene G, Wondifraw H, et al. Assessment of electrolyte imbalance and associated factors among adult diabetic patients attending the university of gondar comprehensive specialized hospital, ethiopia: a comparative cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:1207-20.
Stanimirovic J, Radovanovic J, Banjac K, Obradovic M, Essack M, Zafirovic S, et al. Role of C-reactive protein in diabetic inflammation. Mediators Inflamm. 2022;2022:3706508. PubMed PMID: 35620114
Mohammed JA, Basil B, Mba IN, Abubakar ND, Lawal AO, Momoh JA, et al. Elevated high-sensitivity C-reactive protein and dyslipidaemia in type 2 diabetes mellitus: implications for cardiovascular risk prediction in Nigerian patients. BMC Endocr Disord. 2025;25:100. PubMed PMID: 40247255
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl_1):S19-S40. PubMed PMID: 36507649
Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969;6:24-7.
Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem. 2001;47:1985-92.
Burnett RW, Covington AK, Fogh-Andersen N, Kulpmann WR, Lewenstam A, Maas AH, et al. Use of ion-selective electrodes for blood-electrolyte analysis: recommendations for nomenclature, definitions and conventions. Clin Chem Lab Med. 2000;38:363-70.
Roche Diagnostics GmbH. Magnesium Gen.2 (MG2). Method Sheet. Roche Diagnostics; 2022.
Roberts WL, Moulton L, Law TC, Farrow G, Cooper- Anderson M, Savory J, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem. 2001;47:418-25.
Yun G, Baek SH, Kim S. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean J Intern Med. 2023;38:290-302.
Goia-Nishide K, Coregliano-Ring L, Rangel ÉB. Hyperkalemia in diabetes mellitus setting. Diseases. 2022;10:20. PubMed PMID: 35466190
Al-Daghri NM, Yakout SM, Hussain SD, Alnaami AM, Veronese N, Barbagallo M, et al. Hypomagnesemia in adults with type 2 diabetes mellitus in Riyadh, Saudi Arabia: A cross-sectional study. Medicine (Baltimore). 2025;104:e41253. PubMed PMID: 39833091
Seo YH, Shin HY. Relationship between hs-CRP and HbA1c in Diabetes Mellitus Patients: 2015-2017 Korean National Health and Nutrition Examination Survey. Chonnam Med J. 2021;57:62-7.
Asim M, Amin F, El-Menyar A. Multiple organ dysfunction syndrome: Contemporary insights on the clinicopathological spectrum. Qatar Med J. 2020;2020:22. PubMed PMID: 33628712
Kumar M, Dev S, Khalid MU, Siddenthi SM, Noman M, John C, et al. The bidirectional link between diabetes and kidney disease: mechanisms and management. Cureus. 2023;15:e45615. PubMed PMID: 37868469
